BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $478,836 | -22.7% | 19,910 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $619,442 | +1.6% | 19,400 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $609,950 | -21.7% | 19,920 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $779,071 | -22.2% | 19,920 | -5.3% | 0.00% | -33.3% |
| Q3 2022 | $1,002,000 | +1.6% | 21,030 | -17.5% | 0.00% | +50.0% |
| Q2 2022 | $986,000 | -14.3% | 25,480 | +26.9% | 0.00% | 0.0% |
| Q1 2022 | $1,151,000 | -28.1% | 20,080 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,600,000 | -10.6% | 20,080 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $1,790,000 | -31.8% | 20,567 | +0.9% | 0.00% | -40.0% |
| Q2 2021 | $2,623,000 | +120.8% | 20,377 | +37.3% | 0.01% | +150.0% |
| Q1 2021 | $1,188,000 | -1.7% | 14,845 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,209,000 | – | 14,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |